布地奈德壳聚糖凝胶对鼻内镜术后创面愈合的疗效
结果显示含布地奈德凝胶组各鼻窦开口狭窄程度显著低于对照组,粘连发生率4%对15%。
要点
- 含布地奈德壳聚糖凝胶可减轻鼻内镜术后鼻窦开口狭窄。
- 12个月时该组额窦、蝶窦、上颌窦开口面积保留优于对照组。
- 该组粘连发生率为4%,低于对照组的15%。
核心结论
- 壳聚糖-右旋糖酐凝胶联合局部布地奈德溶液可改善鼻内镜术后长期窦口通畅性并预防窦口狭窄。
研究设计与样本
- 患者左右两侧鼻窦分别接受不同处理:无治疗、壳聚糖-右旋糖酐凝胶、含1 mg/2 mL布地奈德的凝胶、局部激素乳膏。
- 术中及术后2周、3个月、12个月测量窦口面积和内镜下创面愈合特征。
- 数据分析采用方差分析(ANOVA)和事后Tukey真实显著差异(HSD)检验。
主要发现
- 含布地奈德凝胶组与对照组相比,三个鼻窦开口部位的狭窄均显著减少。
- 12个月时额窦开口面积占基线百分比:含布地奈德凝胶组76%±6.2% vs 对照组37%±23.5%(p<0.05)。
- 12个月时蝶窦开口面积占基线百分比:76%±6.3% vs 52%±4.9%(p<0.05)。
- 12个月时上颌窦开口面积占基线百分比:83%±6.5% vs 58%±5.0%(p<0.05)。
- 粘连发生率:含布地奈德凝胶组4%,对照组15%。
临床怎么用
- 鼻内镜术后可考虑使用含布地奈德的壳聚糖-右旋糖酐凝胶作为局部激素递送方式,以减少窦口狭窄和粘连。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adhesion formation and ostial stenosis are common causes of surgical failure after endoscopic sinus surgery (ESS). Postoperative topical steroid application has been shown to improve wound healing. Chitosan-dextran gel (CD gel) is an effective hemostatic nasal dressing. This study aims to determine the effect of the addition of budesonide to CD gel on postoperative ostial stenosis and adhesion formation following ESS. METHODS: This prospective, blinded, randomized controlled trial was conducted between October 2012 and April 2015. Thirty-six patients over 18 years undergoing ESS were randomized to receive either: no treatment, CD gel, CD gel with 1 mg/ 2 mL budesonide, or topical steroid cream to their left or right sinuses (different treatment each side). Each sinus ostium and endoscopic features of wound healing was measured intraoperation, and 2 weeks, 3 months, and 12 months postoperation. RESULTS: Data was analyzed using the analysis of variance (ANOVA) and post hoc Tukey honestly significant difference (HSD) tests. There was a significant reduction in stenosis within all 3 sinuses ostia sites when CD + budesonide was compared to control, with the greatest effect seen at 12 months: The mean ± standard deviation (SD) percentage of baseline areas at 12 months were 76% ± 6.2% vs 37% ± 23.5%, 76% ± 6.3% vs 52% ± 4.9%, and 83% ± 6.5% vs 58% ± 5.0% (all p < 0.05), for CD + budesonide compared to control in the frontal, sphenoid, and maxillary sinuses, respectively. The incidence of adhesions was 4% in the CD + budesonide group compared to 15% in the control group. CONCLUSION: This study has shown that CD gel, when combined with topical budesonide solution, improves long-term sinus ostial patency and prevents ostial stenosis post-ESS.
引用
- Ha T, Valentine R, Moratti S, et al. The efficacy of a novel budesonide chitosan gel on wound healing following endoscopic sinus surgery. Int Forum Allergy Rhinol. 2017. PMID: 29210513. doi:10.1002/alr.22057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。